Ami E. Iskandrian is a Distinguished Professor of Medicine and Radiology in the Division of Cardiovascular Disease at the University of Alabama at Birmingham. University's School of Medicine in Atlanta, Georgia.Fadi G. Hage is a Professor of Medicine in the Division of Cardiovascular Disease at the University of Alabama at Birmingham. He is the Chief of Cardiology at the Birmingham VA Medical Center and the Director of Nuclear Cardiology at the University of Alabama at Birmingham.Fadi G. Hage is a Professor of Medicine in the Division of Cardiovascular Disease at the University of Alabama at Birmingham. He is the Chief of Cardiology at the Birmingham VA Medical Center and the Director of Nuclear Cardiology at the University of Alabama at Birmingham.

• Section I. Historical, Technical and Physiological Considerations 1. Nuclear Cardiology: History and Milestones2. Radiation physics3. SPECT and PET Instrumentation4. Kinetics of Conventional and New Cardiac Radiotracers5. Radionuclide Angiography: Planar and Tomographic6. Gated SPECT MPI: Imaging Protocols and Acquisition7. Image Artifacts Section II. Diagnosis and Risk Assessment 8. Regulation of Myocardial Blood Flow9. How to measure Myocardial Blood Flow by PET?10. How to measure Myocardial Blood flow by SPECT?11. Treadmill Exercise Testing12. Pharmacological Stress Testing13. SPECT MPI in Diagnosis/Risk Assessment14. SPECT MPI for Risk Assessment in special groups (DM, Kidney transplant, Liver transplant, Asymptomatic, Obese)15. SPECT MPI for Risk Assessment before non-cardiac surgery16. Evaluation of patients with Chest Pain in the Emergency Department17. Role of PET (Perfusion and MBF) in Diagnosis and Risk Assessment18. Nuclear Imaging in women19. Myocardial Viability Assessment by Nuclear Techniques Section III. Role of Nuclear Imaging Beyond CAD 20. Imaging dyssynchrony21. Imaging Myocardial Innervation by SPECT and PET22. Imaging sarcoid heart disease23. Imaging Amyloid heart disease24. Imaging infections of valves and devices25. Imaging cardiac and vascular inflammation26. Imaging in Heart Failure including those with devices and post cardiac transplant Section IV. Advances in Nuclear Cardiac Imaging 27. Evolving role of CT, cMR and echo in CAD28. Hybrid Imaging: SPECT/CTA, PET/MR and SPECT Calcium Score: when and why?29. Artificial Intelligence and nuclear imaging30. Nuclear Imaging in patients with serious arrhythmias31. Nuclear Imaging in patients with HIV32. Nuclear Imaging in cardio-oncology33. Nuclear Imaging in patients with congenital heart diseases Section V. Challenges for Nuclear Cardiology 34. Physician Certification and Lab Accreditation35. ACC/AHA/ESC Nuclear Guidelines and Appropriate Use Criteria36. Nuclear Cardiology Report generation37. Radiation Considerations in imaging38. Statistics in Nuclear imaging39. Nuclear Imaging in Developing Countries40. Ask the Experts Section VI. Self-Assessment 41. Nuclear Cardiology Self-Assessment

Ami E. Iskandrian is a Distinguished Professor of Medicine and Radiology in the Division of Cardiovascular Disease at the University of Alabama at Birmingham. University's School of Medicine in Atlanta, Georgia.Fadi G. Hage is a Professor of Medicine in the Division of Cardiovascular Disease at the University of Alabama at Birmingham. He is the Chief of Cardiology at the Birmingham VA Medical Center and the Director of Nuclear Cardiology at the University of Alabama at Birmingham.Fadi G. Hage is a Professor of Medicine in the Division of Cardiovascular Disease at the University of Alabama at Birmingham. He is the Chief of Cardiology at the Birmingham VA Medical Center and the Director of Nuclear Cardiology at the University of Alabama at Birmingham.

• Section I. Historical, Technical and Physiological Considerations 1. Nuclear Cardiology: History and Milestones2. Radiation physics3. SPECT and PET Instrumentation4. Kinetics of Conventional and New Cardiac Radiotracers5. Radionuclide Angiography: Planar and Tomographic6. Gated SPECT MPI: Imaging Protocols and Acquisition7. Image Artifacts Section II. Diagnosis and Risk Assessment 8. Regulation of Myocardial Blood Flow9. How to measure Myocardial Blood Flow by PET?10. How to measure Myocardial Blood flow by SPECT?11. Treadmill Exercise Testing12. Pharmacological Stress Testing13. SPECT MPI in Diagnosis/Risk Assessment14. SPECT MPI for Risk Assessment in special groups (DM, Kidney transplant, Liver transplant, Asymptomatic, Obese)15. SPECT MPI for Risk Assessment before non-cardiac surgery16. Evaluation of patients with Chest Pain in the Emergency Department17. Role of PET (Perfusion and MBF) in Diagnosis and Risk Assessment18. Nuclear Imaging in women19. Myocardial Viability Assessment by Nuclear Techniques Section III. Role of Nuclear Imaging Beyond CAD 20. Imaging dyssynchrony21. Imaging Myocardial Innervation by SPECT and PET22. Imaging sarcoid heart disease23. Imaging Amyloid heart disease24. Imaging infections of valves and devices25. Imaging cardiac and vascular inflammation26. Imaging in Heart Failure including those with devices and post cardiac transplant Section IV. Advances in Nuclear Cardiac Imaging 27. Evolving role of CT, cMR and echo in CAD28. Hybrid Imaging: SPECT/CTA, PET/MR and SPECT Calcium Score: when and why?29. Artificial Intelligence and nuclear imaging30. Nuclear Imaging in patients with serious arrhythmias31. Nuclear Imaging in patients with HIV32. Nuclear Imaging in cardio-oncology33. Nuclear Imaging in patients with congenital heart diseases Section V. Challenges for Nuclear Cardiology 34. Physician Certification and Lab Accreditation35. ACC/AHA/ESC Nuclear Guidelines and Appropriate Use Criteria36. Nuclear Cardiology Report generation37. Radiation Considerations in imaging38. Statistics in Nuclear imaging39. Nuclear Imaging in Developing Countries40. Ask the Experts Section VI. Self-Assessment 41. Nuclear Cardiology Self-Assessment

Ami E. Iskandrian is a Distinguished Professor of Medicine and Radiology in the Division of Cardiovascular Disease at the University of Alabama at Birmingham. University's School of Medicine in Atlanta, Georgia.Fadi G. Hage is a Professor of Medicine in the Division of Cardiovascular Disease at the University of Alabama at Birmingham. He is the Chief of Cardiology at the Birmingham VA Medical Center and the Director of Nuclear Cardiology at the University of Alabama at Birmingham.Fadi G. Hage is a Professor of Medicine in the Division of Cardiovascular Disease at the University of Alabama at Birmingham. He is the Chief of Cardiology at the Birmingham VA Medical Center and the Director of Nuclear Cardiology at the University of Alabama at Birmingham.

• Section I. Historical, Technical and Physiological Considerations 1. Nuclear Cardiology: History and Milestones2. Radiation physics3. SPECT and PET Instrumentation4. Kinetics of Conventional and New Cardiac Radiotracers5. Radionuclide Angiography: Planar and Tomographic6. Gated SPECT MPI: Imaging Protocols and Acquisition7. Image Artifacts Section II. Diagnosis and Risk Assessment 8. Regulation of Myocardial Blood Flow9. How to measure Myocardial Blood Flow by PET?10. How to measure Myocardial Blood flow by SPECT?11. Treadmill Exercise Testing12. Pharmacological Stress Testing13. SPECT MPI in Diagnosis/Risk Assessment14. SPECT MPI for Risk Assessment in special groups (DM, Kidney transplant, Liver transplant, Asymptomatic, Obese)15. SPECT MPI for Risk Assessment before non-cardiac surgery16. Evaluation of patients with Chest Pain in the Emergency Department17. Role of PET (Perfusion and MBF) in Diagnosis and Risk Assessment18. Nuclear Imaging in women19. Myocardial Viability Assessment by Nuclear Techniques Section III. Role of Nuclear Imaging Beyond CAD 20. Imaging dyssynchrony21. Imaging Myocardial Innervation by SPECT and PET22. Imaging sarcoid heart disease23. Imaging Amyloid heart disease24. Imaging infections of valves and devices25. Imaging cardiac and vascular inflammation26. Imaging in Heart Failure including those with devices and post cardiac transplant Section IV. Advances in Nuclear Cardiac Imaging 27. Evolving role of CT, cMR and echo in CAD28. Hybrid Imaging: SPECT/CTA, PET/MR and SPECT Calcium Score: when and why?29. Artificial Intelligence and nuclear imaging30. Nuclear Imaging in patients with serious arrhythmias31. Nuclear Imaging in patients with HIV32. Nuclear Imaging in cardio-oncology33. Nuclear Imaging in patients with congenital heart diseases Section V. Challenges for Nuclear Cardiology 34. Physician Certification and Lab Accreditation35. ACC/AHA/ESC Nuclear Guidelines and Appropriate Use Criteria36. Nuclear Cardiology Report generation37. Radiation Considerations in imaging38. Statistics in Nuclear imaging39. Nuclear Imaging in Developing Countries40. Ask the Experts Section VI. Self-Assessment 41. Nuclear Cardiology Self-Assessment